Lucid Capital Markets Reiterates Buy Rating on Coya Therapeutics (COYA), PT $20
Tweet Send to a Friend
Lucid Capital Markets analyst Elemer Piros reiterated a Buy rating and $20.00 price target on Coya Therapeutics (NASDAQ: COYA).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
